Integratore alimentare a base di Reishi, Cognivia™ e Bacopin® utile per migliorare memoria e concentrazione ottimizzando la performance cognitiva e riducendo la percezione dello stress durante ogni performance.

Finalità salutistiche:
Performance Brain è una sinergia “nootropa” creata per ottimizzare le funzioni cognitive, la performance fisica e mentale per tutti coloro sottoposti a stress fisico e psichico che necessitano di un potenziamento delle capacità di attenzione, concentrazione e focalizzazione per il raggiungimento della prestazione ottimale, con riferimento particolare a sportivi sia d’élite che master.

Proprietà dei componenti:

  • Reishi (Ganoderma lucidum) BIO: è uno dei funghi più utilizzati dagli sportivi: aumenta i livelli di energia, migliora la respirazione cellulare, protegge la funzione mitocondriale dallo stress ossidativo, riduce l’infiammazione cronica di basso grado, contrasta la stanchezza psico-fisica migliorando anche memoria e concentrazione focalizzata. Grazie all’elevata presenza di triterpeni modula l’asse dello stress, sostiene le ghiandole surrenali e l’asse ipotalamo-ipofisi-surreni, riduce la sensazione di fatica, regola­rizzando i ritmi del sonno
  • Cognivia™: unisce le proprietà di due specie di Salvia, la Salvia officinalis, che migliora la performance cognitiva aumentando la focalizzazione sul raggiungimento degli obiettivi, e gli oli essenzia­li di Salvia lavandulifolia che velocizzano i processi mnemonici. Gli studi effettuati dimostrano un aumento delle funzioni cognitive e dei processi di memoria a lungo termine ed esecutiva, già dopo una sola somministrazione.
  • Bacopin®: (estr. standardizzato di Bacopa monnieri tit.20% Bacosidi): favorisce il potenziamento della memoria, della concentra­zione e delle funzioni cognitive. A livello fisico la Bacopa contribuisce a migliorare la performance sportiva alleviando l’affaticamento muscolare e aumentando le riserve di glicogeno muscolare. A livello cogniti­vo migliora la velocità di reazione, l’attenzione e la memoria spaziale e di lavoro aumentando la prontezza dei riflessi
  • Newcaff® (Caffeina microincapsulata): la caffeina è una sostanza ergogenica, la microincapsulazione ne migliora la biodisponibilità permettendone un rilascio controlla­to e prolungato nel tempo nell’arco di 4 ore. La sua efficacia è stata dimostrata sia in atleti soggetti a sforzo prolungato, con sprint in­termittenti, sia negli atleti di resistenza e anche negli sport di potenza e di forza senza alterare i livelli di insulina e glu­cosio nel sangue

Modalità d’uso:
Si consiglia di assumere 1 capsula al giorno come mantenimento, quindi aumentare la dose di 1 capsula ogni giorno già due giorni prima della gara e 4 capsule il giorno della performance

Formato:
confezione da 60 capsule

Note:

PlaySure Prodotto certificato Play Sure-Doping Free

Codice EAN: 8059173430123

TENORE MEDIO INGREDIENTI PER DOSE GIORNALIERA (3 CPS)
Ganoderma lucidum (Reishi) 565 mg
Cognivia® (Salvia officinalis e Salvia lavandulifolia) 500 mg
Bacopin® (Bacopa monnieri) tit. 20% 570 mg
Apporto bacosidi 114 mg
Caffeina 75 mg

Bibliografia:

  1. Potgieter, S et al. “Caffeine improves triathlon performance: a field study in males and females.” International journal of sport nutrition and exercise metabolism 28.3 (2018): 228-237.
  2. Schneiker, KT, et al. “Effects of caffeine on prolonged intermittent-sprint ability in team-sport athletes.” Medicine and science in sports and exercise 38.3 (2006): 578-585.
  3. Stuart, GR., et al. “Multiple effects of caffeine on simulated high-intensity team-sport performance.” Medicine and science in sports and exercise 37.11 (2005): 1998.
  4. Evans, Mark, et al. “Acute Ingestion of Caffeinated Chewing Gum Improves Repeated Sprint Performance of Team Sport Athletes With Low Habitual Caffeine Consumption.” International journal of sport nutrition and exercise metabolism 28.3 (2018): 221-227.
  5. López-González, LM., et al. “Acute caffeine supplementation in combat sports: a systematic review.” Journal of the international society of sports nutrition 15.1 (2018): 60.
  6. Brooks, JH., et al. “Caffeine supplementation as an ergogenic aid for muscular strength and endurance: a recommendation for coaches and athletes.” (2016).
  7. Nehlig, Astrid. “Is caffeine a cognitive enhancer?.” Journal of Alzheimer’s Disease 20.s1 (2010): S85-S94.
  8. Panza, F, et al. “Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.” The journal of nutrition, health & aging 19.3 (2015): 313-328.
  9. Tildesley N.T.J. et al. Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiology & Behavior 83 (2005) 699-709
  10. Kennedy D.O. et al. Effects of Cholinesterase Inhibiting Sage (Salvia officinalis) on Mood, Anxiety, and Performance on a psychological Stressor Battery. Neuropsychopharmacology (2006) 31, 845-852
  11. Scholey A.B. et al. An extract of Salvia (Sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology (2008) 198:127-139
  12. Tildesley N.T.J. et al. Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers. Pharmacology, Biochemistry and Behavior (2003) 75: 669-674.
  13. Kennedy D.O. et al. Monoterpenoid extract of Sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults. Journal of Psychopharmacology. (2011) 25(08): 1088-1100.
  14. Pase, MP., et al. “The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.” The Journal of Alternative and Complementary Medicine 18.7 (2012): 647- 652.
  15. Roodenrys, S, et al. “Chronic effects of Brahmi (Bacopa monnieri) on human memory.” Neuropsychopharmacology 27.2 (2002): 279.
  16. Calabrese, C, et al. “Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.” The journal of alternative and complementary medicine 14.6 (2008): 707-713.
  17. Chaudhari, KS., et al. “Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer’s disease.” Annals of neurosciences 24.2 (2017): 111-122.
  18. Simpson, T et al. “Bacopa monnieri as an antioxidant therapy to reduce oxidative stress in the aging brain.” Evidence-Based Complementary and Alternative Medicine 2015 (2015).
  19. Nemetchek, MD., et al. “The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain.” Journal of ethnopharmacology 197 (2017): 92-100.
  20. Shinomol, GK et al. “Bacopa monnieri extract offsets rotenone-induced cytotoxicity in dopaminergic cells and oxidative impairments in mice brain.” Cellular and molecular neurobiology 32.3 (2012): 455-465.
  21. Swathi, G, et al. “Alterations of cholinergic neurotransmission in rotenone induced Parkinson’s disease: protective role of Bacopa monnieri.” Int J Pharm Biol Sci 3 (2013): 286-292.
  22. Hosamani, R. “Prophylactic treatment with Bacopa monnieri leaf powder mitigates paraquat-induced oxidative perturbations and lethality in Drosophila melanogaster.” (2010).
  23. Krishna, G., et al. “Bacopa monnieri Supplements Offset Paraquat-Induced Behavioral Phenotype and Brain Oxidative Pathways In Mice.” Central nervous system agents in medicinal chemistry (2019).
  24. Chen, Zhidan, et al. “Pharmaceutical composition and drug effect of synthetic Bacopa monnieri L. health promoting agent from the perspective of resistance fatigue.” Pakistan journal of pharmaceutical sciences 30 (2017).
  25. Kennedy, David O. “Phytochemicals for improving aspects of cognitive function and psychological state potentially relevant to sports performance.” Sports Medicine (2018): 1-20.
  26. Peth-Nui T, et al. Effects of 12-week Bacopa monnieri consumption on attention, cognitive processing, working memory, and functions of both cholinergic and monoaminergic systems in healthy elderly volunteers.
  27. Evid Based Complement Alternat Med. 2012;2012:606424.
  28. Tang, W, et al. “A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia.” Journal of medicinal food 8.1 (2005): 53-58.
  29. Zhang, XQ, et al. “Triterpenoids with neurotrophic activity from Ganoderma lucidum.” Natural product research 25.17 (2011): 1607-1613.
  30. Zhang, R, et al. “Ganoderma lucidum protects dopaminergic neuron degeneration through inhibition of microglial activation.” Evidence-Based Complementary and Alternative Medicine 2011 (2011).
  31. Cui, XY, et al. “Extract of Ganoderma lucidum prolongs sleep time in rats.” Journal of ethnopharmacology 139.3 (2012): 796-800.
  32. Cai, Q, et al. “Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response.” Journal of neuroinflammation 14.1 (2017): 63.
  33. Jin, M, et al. “Effects of polysaccharide from mycelia of Ganoderma lucidum on intestinal barrier functions of rats.” International journal of biological macromolecules 94 (2017): 1-9.
  34. Chang, CJ, et al. “Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota.” Nature communications 6 (2015): 7489.
  35. Kaur, R et al. “Anti-amnesic effects of Ganoderma species: a possible cholinergic and antioxidant mechanism.” Biomedicine & Pharmacotherapy 92 (2017): 1055-1061.
  36. Khatian, N, et al. “Effect of Ganoderma lucidum on memory and learning in mice.” Clinical Phytoscience5.1 (2019): 4.
  37. Zhang, Y, et al. “Influence of Ganoderma lucidum triterpenoids on learning memory function and ACh content in Alzheimer disease model rat.” Chin J Exp Tradit Med Formulae 16.16 (2012): 172-175.
  38. Huang, S, et al. “Polysaccharides from Ganoderma lucidum promote cognitive function and neural progenitor proliferation in mouse model of Alzheimer’s disease.” Stem cell reports 8.1 (2017): 84-94.